Pneumonia is one of the common diseases in pediatrics. It is a respiratory infectious diseases with cough, expectoration and fever as the main symptoms caused by the pathogen invading the bronchus. With the continuous development of the disease, it can gradually evolve into severe pneumonia, which involves the circulatory, digestive, and neurological systems of the organisms, and seriously threatens the lives of the children. At present, modern Western medicine mainly focuses on antibiotic treatment, but the problems of antibiotic abuse and pathogen resistance are becoming increasingly serious. Traditional Chinese medicine therapy has good efficacy and unique advantages in treating severe cases of bronchopneumonia. This article reviews the pathogenesis and clinical treatment progress of this disease, aiming to provide reference for its clinical treatment.

Qizhi Yang, Yaxiong Guo. Pathogenesis and Current Status of Treatment of Severe Pneumonia in Chinese and Western Medicine. Frontiers in Medical Science Research (2023) Vol. 5, Issue 9: 104-111. https://doi.org/10.25236/FMSR.2023.050918.

[1] Hu Jingkang, Xu Baoping, Shen Kunling. Analysis of hospitalization cost and its influencing factors of pediatric pneumonia patients in a hospital in Beijing [J]. Chinese Journal of Health Information Management, 2018, 15(2):211-216. 

[2] Holloway JW, DeMeo DL. Omics and lung function: a need for inte- gration [J]. Am Respir Crit Care Med, 2022, 206(3): 242-244. 

[3] Zou Yingxue, Zhao Shunying, Liu Hanmin. Expert consensus on clinical early warning and early decision-making for severe pneumonia in children [J]. Chinese Journal of Practical Pediatrics, 2023, 38(03):177-182. 

[4] Wang Lingli, Qu Saihua, Wang Dezhi. Effect of budesonide and ipratropium bromide combined with salbutamol nebulized inhalation in the treatment of pediatric bronchopneumonia and its effect on TGF-β1 and CRP [J]. Journal of Hunan Normal University (Medical Edition), 2021, 18(4):230-233. 

[5] Zhang Juansheng, Li Hao, Wei Xiaoguang, et al. Resistance to macrolide antibiotics, resistance-associated molecular characterization and PFGE phenotypic characterization of Bortetella pertussis [J]. Chinese Journal of Microbiology and Immunology, 2021, 41(12):901-905. 

[6] Sonaglioni Andrea, Caminati Antonella, Re Margherita, et al. Prognostic role of CHA2DS2-VASc score for mortality risk assessment in non-advanced idiopathic pulmonary fibrosis: a preliminary observation [J]. Internal and emergency medicine, 2023, 18(3):755-767. 

[7] Song Xixi, Li Zhihong, Li Ruixue et al. Relationship between promoter DNA methylation of vitamin D receptor gene and type 2 diabetes mellitus combined with osteoporosis [J]. Journal of Xinjiang Medical University, 2022, 45(12):1426-1430. 

[8] Mpody Christian, Hayes Seth, Rusin Nathan, et al. Risk Assessment for Postoperative Pneumonia in Children Living With Neurologic Impairments [J]. Pediatrics, 2021, 148(3) 

[9] Yang Shenglin. Immune effects of vitamin D deficiency on severe pneumonia in children [J]. Famous doctors, 2022(19):84-86. 

[10] Zhang Liguo. Publication of Clinical Management of Pediatric Pneumonia: a study of the correlation between vitamin A, D, E levels and severe pneumonia infection in infants and children [J]. Journal of Interventional Radiology, 2023, 32(05):525. 

[11] Zhang Zhengjuan, Zheng Yuejie. Current research on the relationship between vitamins A, E, and D and community-acquired pneumonia in children [J]. Chinese Community Physician, 2020, 36(29): 92-93. 

[12] Li Jianmei, Dang Aibing, Xu Feng. Mechanisms by which regulatory T cells promote β-conjugated protein-mediated epithelial-to-mesenchymal transition and development of pulmonary fibrosis in rats with severe pneumonia in vivo [J]. Journal of Clinical and Experimental Medicine, 2020, 19(07):717-722. 

[13] Yu Fei, Wang Xiangyu, Liu Zhiyong. Effects and mechanism of qinpiin on lung tissue injury and fibrosis in rats with severe pneumonia caused by Klebsiella pneumoniae [J]. Chinese Journal of Traditional Chinese Medicine, 2023, 41(01):197-200+290.

[14] Lv Beili, Zhang Xiaofeng, Cai Liming et al. Relationship between HSP70 gene polymorphisms and clinical regression of severe pneumonia [J]. Chinese Journal of Hospital Infection, 2021, 31(14): 2139-2143. 

[15] Zhang Lulu, Liang Bing, Han Fei, et al. Association of PPAR-γ gene polymorphisms with severe pneumonia in children [J]. Chinese Journal of Hospital Infection, 2023, 33(11):1726-1730. 

[16] Dong Shangjuan, Shi Liqing, Ji Kun, et al. Discussion on the characteristics of lung-spleen related pathomechanism in elderly wind-temperature and lung-heat disease [J]. Modern Chinese Medicine Clinic, 2019, 26(03):59-62. 

[17] Zhang Ye, Wu Liqun, Chen Haipeng. Exploring the treatment of severe pneumonia in children from phlegm toxicity [J]. China TCM Emergencies, 2022, 31(02):247-250. 

[18] Lan Jiaxin, Han Yun, Lai Fang. Application of Chinese medicine's "treating the future disease" in the prevention and treatment of severe pneumonia [J]. China TCM Emergencies, 2021, 30(08): 1412-1415+1419. 

[19] Lin Yanlin. A study on the distribution characteristics of Chinese medicine evidence of severe pneumonia in ICU [J]. Chinese contemporary medicine, 2020, 27(32):16-19. 

[20] Zhou Yongfang. Clinical Application of Low-dose Dopamine Combined with Dobutamine in the Treatment of Severe Pneumonia in Children [J]. World Journal of Complex Medicine, 2019, 5(1): 58-60. 

[21] Zhao Qingkun, Liu Yue, Ma Tongshuai. Effect of low-dose dopamine and dobutamine combination on clinical efficacy and serum inflammatory factor in children with severe pneumonia [J]. China Rational Drug Use Exploration, 2023, 20(06):38-43. 

[22] Zhou Dayong. Observation on the efficacy of fiberoptic bronchoscopic alveolar lavage in the treatment of severe pneumonia [J]. China Community Physician, 2019, 35(03):97+100. 

[23] Zhang Yucai, Hong Xiaoyang, Lu Xiulan, et al. Expert consensus on the use of sevelamer sodium in pediatric intensive care medicine [J]. Chinese Journal of Practical Pediatrics, 2023, 38(05): 321-326.

[24] Chao Yiqun, Zhou Jie, Huang Jieyuan, et al. Impact of immunotherapy on the clinical efficacy of severe pneumonia in the elderly [J]. Chinese Journal of Gerontology, 2019, 39(06):1348-1350. 

[25] Hu Ziran, Liu Fengjuan, Li Lu. The application value of Qing Jin Resolving Phlegm and Benefiting Lung Tang combined with Bao He Wan in bronchopneumonia and the effects on lung function, immune function, FeNO, EOS, PCT and CRP levels [J/OL]. Chinese Archives of Traditional Chinese Medicine,1-7[2023-09-16].http://kns.cnki.net/kcms/detail/21.1546.R.20230728.1419.006.html. 

[26] He Chaonan, Hu Yong, Chen Jianwei, et al. Clinical observation on the adjunctive treatment of severe pneumonia of phlegm-heat stagnation type with Shengsheng Powder [J]. Chinese Journal of Traditional Medical Science and Technology, 2023, 30(1): 164-166

[27] Qiang Weiping, Fu Chengbao, Guan Shujun. Effect of the treatment of severe pneumonia (phlegm-heat congested lung type) with the addition and subtraction of elevation and dispersion and its effect on inflammatory factors and peripheral blood T-lymphocyte population [J]. Hainan Medicine, 2023, 34(14):1993-1997. 

[28] Wang Liang, Tao Yulong, Chen Wansheng. Progress of chemical composition, pharmacological effect and clinical application of Phlegm Fever Qing Injection [J]. Chinese Herbal Medicine, 2020, 51(12):3318-3328. 

[29] Chen Weitao, Yuan Tianhui, Zhan Shaofeng, et al. Report of a real-world clinical study of phlegm-heat-clearing injection for the treatment of novel coronavirus-infected pneumonia [J]. Journal of Guangzhou University of Traditional Chinese Medicine, 2022, 39(03):463-468.

[30] Ma Jianping. Observation on the efficacy of Wakebrain Jing Injection combined with azithromycin in the treatment of severe pneumonia in the elderly and its effect on lung function and inflammatory factor level [J]. New Chinese Medicine, 2023, 55(14):47-50.

[31] Xie Yun, Gao Jiao, Ren Mao, et al. Clinical observation on the treatment of severe pneumonia in the elderly with Qianjin Reed Stem Tang combined with the addition and subtraction of Ma Xing Shi Gan Tang combined with Thymus Faxin [J]. Hebei Traditional Chinese Medicine, 2023, 45(08): 1292-1296+1301. 

[32] Ge Yanping, Wang Shaoqian, Kong Jing. Effect of Qingfei Huatan Decoction on the TCM Syndrome Score,Immune Function and Inflammatory Factors in Patients with Severe Pneumonia(Syndrome of Phlegm-heat Obstructing Lung) [J]. Journal of Emergency in Traditional Chinese Medicine, 2022, 31(08):1213-1216.